Home » Stocks » Therapix Biosciences

Therapix Biosciences Ltd. (TRPXY)

Stock Price: $0.170 USD 0.000 (0.00%)
Updated Aug 3, 2020 5:19 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 972,349
Revenue (ttm) n/a
Net Income (ttm) -4.58M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $0.170
Previous Close $0.170
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.143
Day's Range 0.143 - 0.170
Day's Volume 110,961
52-Week Range 0.100 - 0.230

More Stats

Market Cap 972,349
Enterprise Value 253,349
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding n/a
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.39
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 69.45
Revenue n/a
Operating Income -4.11M
Net Income -4.58M
Free Cash Flow -3.97M
Net Cash 719,000
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC 685.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$18.00*
Low
18.0
Current: $0.170
High
18.0
Target: 18.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-4.11-7.24-5.75-2.01-1.60-7.04
Net Income-4.58-9.38-6.241.992.54-7.21
Shares Outstanding20414041.0041.00--
Earnings Per Share0.641.201.00-1.00-2.20-9.00
EPS Growth-46.67%20%----
Operating Cash Flow-4.70-7.13-4.58-1.47-1.40-7.36
Capital Expenditures0.720.03-0.04--0.22
Free Cash Flow-3.97-7.11-4.62-1.48-1.40-7.14
Cash & Equivalents0.882.039.220.696.180.66
Total Debt0.160.87----
Net Cash / Debt0.721.169.220.696.180.66
Assets1.154.569.571.256.501.02
Liabilities1.144.481.180.671.991.47
Book Value0.010.198.390.575.11-0.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Therapix Biosciences Ltd.
Country Israel
CEO Gilad Bar-Lev

Stock Information

Ticker Symbol TRPXY
Stock Exchange US OTC
Unique Identifier OTCMKTS: TRPXY
IPO Date March 22, 2017

Description

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel.